Myalept tops the list of the most expensive drugs currently sold in the United States, as compiled by GoodRx. Used to treat leptin deficiency, Myalept carries a list price of $71,306 for a 30-day prescription. Mavenclad, a multiple sclerosis treatment, follows at $56,954 for a 30-day supply.

Many of the drugs listed are used to treat rarer conditions such as cancer and hepatitis C, in addition to multiple sclerosis and leptin deficiency. These medications are often available only through specialty pharmacies and can sometime serve as an alternative to prolonged medical treatment.
It should be noted, however, that certain high-priced specialty drugs are merely two or more lower-cost medications combined into one pill that’s more “convenient” to patients. To protect your plan against this practice, MedBen offers a discretionary formulary that targets high-cost drugs which have low-cost generics available. To learn more, contact your Account Management team and they will be happy to assist you.